Brief: Heidelberg Pharma Raises 2019 Guidance

Heidelberg Pharma AG

10/10/2019 06:23

Oct 10 (Reuters) - HEIDELBERG PHARMA AG  WL6G.DE :
    * 2019 GUIDANCE RAISED AFTER YEAR-ON-YEAR DOUBLING OF SALES
REVENUE
    * 9-MONTH SALES REVENUE AND INCOME TOTALING EUR 6.7 MILLION
(PREVIOUS YEAR: EUR 3.5 MILLION)
    * NET LOSS FOR FIRST NINE MONTHS OF FISCAL YEAR FELL TO EUR
5.6
MILLION (PREVIOUS YEAR: EUR 7.4 MILLION)
    * OUTLOOK 2019: BETWEEN EUR 7.5 MILLION AND EUR 8.5 MILLION
IN
SALES REVENUE AND OTHER INCOME (PREVIOUSLY: BETWEEN EUR 5.0
MILLION AND EUR 7.0 MILLION)
    * OUTLOOK 2019: EBIT BETWEEN EUR -7.5 MILLION AND EUR - 9.5
MILLION (PREVIOUSLY: BETWEEN EUR -8.0 MILLION AND EUR -12.0
MILLION)

Source text for Eikon:  ID:nEQbPmDZKa 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))